Influenza vaccine recommendations for children and youth for the 2013/2014 season
Author(s) -
Dorothy Moore
Publication year - 2013
Publication title -
paediatrics and child health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.55
H-Index - 43
eISSN - 1918-1485
pISSN - 1205-7088
DOI - 10.1093/pch/18.8.e51
Subject(s) - live attenuated influenza vaccine , medicine , vaccination , influenza vaccine , immunization , pediatrics , population , influenza season , nasal administration , immunology , environmental health , antibody
Recommendations from the National Advisory Committee on Immunization concerning indications for the routine influenza vaccination of children and their close contacts have not changed from those of 2012/2013. Intranasal, live attenuated influenza vaccine (LAIV) is preferred over trivalent inactivated influenza vaccines (TIV) for healthy children and youth. There is insufficient evidence to recommend LAIV over TIV in children with chronic health conditions; either may be used unless there are specific contraindications. TIV may be used in persons with egg allergy; LAIV has not yet been evaluated in this population and is not recommended at this time.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom